BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33982138)

  • 1. False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use.
    Domper Arnal MJ; García Mateo S; Hermoso-Durán S; Abad D; Carrera-Lasfuentes P; Velazquez-Campoy A; Abian Franco O; Lanas A
    Int J Colorectal Dis; 2021 Sep; 36(9):1861-1869. PubMed ID: 33982138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibitors are associated with a high false-positivity rate in faecal immunochemical testing.
    Ibáñez-Sanz G; Milà N; de la Peña-Negro LC; Garcia M; Vidal C; Rodríguez-Alonso L; Binefa G; Rodríguez-Moranta F; Moreno V
    J Gastroenterol; 2021 Jan; 56(1):42-53. PubMed ID: 33159805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
    de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
    Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.
    Nielson CM; Petrik AF; Jacob L; Vollmer WM; Keast EM; Schneider JL; Rivelli JS; Kapka TJ; Meenan RT; Mummadi RR; Green BB; Coronado GD
    Cancer Med; 2018 Sep; 7(9):4781-4790. PubMed ID: 30101513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
    Ibáñez-Sanz G; Garcia M; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Domènech X; Vidal C; Soriano A; Moreno V;
    Dig Liver Dis; 2016 Oct; 48(10):1249-54. PubMed ID: 27378703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results.
    van Turenhout ST; Oort FA; Terhaar sive Droste JS; Coupé VM; van der Hulst RW; Loffeld RJ; Scholten P; Depla AC; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG
    Gastrointest Endosc; 2012 Jul; 76(1):136-43. PubMed ID: 22726472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
    Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of demographics in noninvasive testing for colorectal cancer screening: do targeted cut-off values improve detection?
    Gill I; Shams C; Hanna A; George J; Jamil LH; Patel A
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):459-469. PubMed ID: 35343664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study.
    Amitay EL; Cuk K; Niedermaier T; Weigl K; Brenner H
    Int J Cancer; 2019 May; 144(10):2419-2427. PubMed ID: 30411799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
    Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
    J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the faecal immunochemical test for the detection of colorectal neoplasms and the role of proton pump inhibitors in their diagnostic accuracy.
    Chandrapalan S; Hee SW; Widlak MM; Farrugia A; Alam MT; Smith S; Arasaradnam RP
    Colorectal Dis; 2021 Jul; 23(7):1649-1657. PubMed ID: 33991166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
    Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
    PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
    Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aspirin, warfarin, and proton-pump inhibitors on performance of fecal immunochemical test in colorectal cancer screening: a systematic review and meta-analysis.
    Han Z; Nan X; Ma M; Zhou R; Wang P; Liu J; Li Y; Li Y
    Clin Exp Med; 2023 Dec; 23(8):4355-4368. PubMed ID: 37804359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.